Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience

Horgan, C., Elmoamly, S., McIlroy, G. et al. (9 more authors) (2019) Reduced intensity alemtuzumab-containing allogeneic stem cell transplantation for relapsed/refractory low grade lymphoma : reflections on a single center experience. Leukemia & Lymphoma, 60 (12). pp. 3075-3077. ISSN 1042-8194

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Informa UK Limited, trading as Taylor & Francis Group.
Keywords: Alemtuzumab; Antineoplastic Agents, Immunological; Cause of Death; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Prognosis; Recurrence; Retreatment; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome
Dates:
  • Accepted: 8 April 2019
  • Published (online): 13 May 2019
  • Published: 15 October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Academic Unit of Medical Education (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 24 Feb 2022 12:35
Last Modified: 24 Feb 2022 12:35
Status: Published
Publisher: Taylor & Francis
Refereed: Yes
Identification Number: https://doi.org/10.1080/10428194.2019.1607323
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)